Loading company…
PACT Pharma is a South San Francisco biotechnology company developing personalized cancer therapies based on cell therapy technology.
Founded in 2016 and headquartered in South San Francisco, US, PACT Pharma develops personalized T-cell therapies designed to target specific cancer cells. Its most recent round, a Series C led by Vida Ventures on September 30, 2022, raised USD 45.37 mn, bringing total funding to USD 45.37 mn at a current valuation of USD 292.96 mn. CEO Scott Garland leads the company, which agreed to an acquisition by AmplifyBio in September 2022.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in